Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPAC with Doxorubicin and Cisplatin in Gastric Carcinomatosis
NCT04065139Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2020
- Primary completion
- Mar 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, cisplatin in gastric adenocarcinoma, peritoneal carcinomatosis (PC), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2020; status: completed.
02
Drugs
doxorubicincisplatin
03
Conditions
gastric adenocarcinomaperitoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT04065139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04065139.